Ipsen
Michael Monteiro is an experienced professional in the field of external research and collaboration, currently serving as Senior Director at Ipsen from September 2021 to August 2024. Prior to this role, Michael held positions including Director at ZebiAI Therapeutics and Management Consultant at Catenion, where the focus was on evaluating clinical stage oncology programs. Michael's career also includes significant contributions as Principal Scientist at X-Chem, Inc. and as Associate Scientist at CombinatoRx, Inc. Michael earned a Ph.D. in Cellular and Molecular Physiology from Tufts University Sackler School of Biomedical Science and a Bachelor of Arts in Biology from Boston University.
This person is not in any teams
This person is not in any offices